Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Clinical Cutting Edge

Jane Jerrard  |  July 1, 2007

Looking for cutting edge clinical information? Here are some treatment advance updates from the ACR State-of-the-Art Clinical Symposium. See the June issue here.

Strides in Diagnosing, Treating Sjögren’s

“One interesting change is the prevalence of Sjögren’s,” said Frederick B. Vivino, MD, a rheumatologist at Penn Rheumatology Associates and the Sjögren’s Syndrome Center in Philadelphia. “Many experts consider it to be the second most common autoimmune rheumatic disease.” In his presentation, “Sjögren’s Syndrome: Comprehensive Diagnosis and Management,” he stressed that, “just like in lupus, you’re dealing with an entire spectrum of disease.” Dr. Vivino reviewed diagnosis of Sjögren’s, including unusual presentations of symptoms like inflammatory myositis, fever of unknown origin, chronic fatigue syndrome, elevated erythrocyte sedimentation rate, and leukocytoclastic vasculitis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Sicca symptoms may be minimal or nil,” warned Dr. Vivino. There may be a discrepancy between symptoms and results of objective tests of eye and mouth dryness. “The bottom line is that if you have a patient with symptoms that fit, you’re obligated to order tests for Sjögren’s.”

He stressed using the American-European criteria for earlier and better diagnosis of Sjögren’s syndrome. “These criteria are in use in nearly every children’s center in the world,” said Dr. Vivino. “They clearly represent an advance over what we had before.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The criteria call for four of the following six symptoms to be present for diagnosis:

Subjective

  • Dry eye symptoms; and
  • Dry mouth symptoms.

Objective

  • Abnormal test for dry eyes;
  • Abnormal test for dry mouth;
  • Positive anti-SSA/SSB*; or
  • Positive lip biopsy.*

*Required

“One of the four objective criteria must be proof of the presence of autoantibodies,” Dr. Vivino pointed out. “This clearly represents an advance over what we had before.”

Errors are often made in reading salivary gland biopsies; a previous study by Dr. Vivino found that 53% of 60 accessions had errors. Other problems include lack of focus score, misinterpretation of focus score, and failure to examine all sections. “It behooves us to talk to our pathologists about accurate test results,” he said.

He pointed out that Sjögren’s can lead to a lot of disease complications, specifically lymphoma. “Lymphomas are the most important cause of morbidity and mortality in Sjögren’s syndrome patients,” said Dr. Vivino. “This is confusing, but the best predictors of lymphomagenesis include persistent parotid enlargement, persistent lymphadenopathy, palpable purpura, mixed monoclonal cryoglubulinemia, and low complement of C4.”

As for symptoms, there has been recent progress in treating dry eyes. This symptom has greatest quality-of-life effect. Research has shown that inflammation is tied to dry-eye disease. New evidence points to secretagogues, such as pilocarpine and cevimeline, that can alleviate symptoms. Fatty acids seem to play a role as well.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsMyositisSjögren’s DiseaseVasculitis Tagged with:Diagnostic CriteriaMeetingmyositisSjogren'sTreatmentVasculitis

Related Articles

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    Autoantibodies in Autoimmune Myopathy

    Autoantibodies in Autoimmune Myopathy

    September 18, 2017

    In recent years, scientists and clinicians have learned a great deal about autoantibodies occurring in idiopathic inflammatory myopathies (IIMs). These new discoveries have reshaped our understanding of distinct clinical pheno­types in IIMs. Scientists continue to learn more about how these auto­antibodies shape pathophysiology, diagnosis, disease monitoring, prognosis and optimum treatment. Moving forward, these autoantibodies will…

    Myositis Mysteries

    January 1, 2008

    Why isn’t my myositis patient getting better?

    Diagnosis: Myopathy

    July 1, 2009

    Presentation and evaluation of metabolic causes

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences